ICD-11 classes
02 Neoplasms
Malignant neoplasms, except primary neoplasms of lymphoid,...
Malignant neoplasms, stated or presumed to be primary, of...
Malignant mesenchymal neoplasms
2B57 — Kaposi sarcoma, primary site
ICD-11 2B57 — Kaposi sarcoma, primary site
A malignant neoplasm characterised by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
The diagnosis includes nothing.
The diagnosis excludes nothing.
Diagnosis with code 2B57 contains 5 clarifying diagnoses:
- 2B57.0 — Kaposi sarcoma of lung
- 2B57.1 — Kaposi sarcoma of skin
- 2B57.2 — Kaposi sarcoma of gastrointestinal sites
- 2B57.Y — Kaposi sarcoma of other specified primary sites
- 2B57.Z — Kaposi sarcoma of unspecified primary site
The diagnosis is coded elsewhere:
- Malignant mesenchymal neoplasms #11858
- Kaposi sarcoma, primary site #11901
- Malignant mesenchymal neoplasms #18235
- Kaposi sarcoma, primary site #18278
The diagnosis is included in 1 another class.
- Human immunodeficiency virus disease associated with Kaposi sarcoma (1C62.3)